The αvβ3 integrin as a molecular target for anticancer drug design

1997 ◽  
Vol 33 ◽  
pp. S173
Author(s):  
R. Allman ◽  
W.G. Jiang ◽  
P. Cowbum ◽  
M. Mason
Keyword(s):  
Drug Design ◽  
Anticancer Drug ◽  
Molecular Target ◽  
Αvβ3 Integrin

scholarly journals Impact of Molybdenum Compounds as Anticancer Agents

2019 ◽  
Vol 2019 ◽  
pp. 1-9
Author(s):  
Ayodele T. Odularu ◽  
Peter A. Ajibade ◽  
Johannes Z. Mbese
Keyword(s):  
Breast Cancer ◽  
Drug Design ◽  
Combination Therapy ◽  
Physicochemical Properties ◽  
Case Studies ◽  
Anticancer Drug ◽  
Oesophageal Cancer ◽  
Anticancer Agents ◽  
Cancer Disease ◽  
Molybdenum Compound

The aim of this mini review was to report the molybdenum compound intervention to control cancer disease. The intervention explains its roles and progress from inorganic molybdenum compounds via organomolybdenum complexes to its nanoparticles to control oesophageal cancer and breast cancer as case studies. Main contributions of molybdenum compounds as anticancer agents could be observed in their nanofibrous support with suitable physicochemical properties, combination therapy, and biosensors (biomarkers). Recent areas in anticancer drug design, which entail the uses of selected targets, were also surveyed and proposed.

Protein-protein interaction inhibitors: advances in anticancer drug design

2016 ◽  
Vol 11 (10) ◽  
pp. 957-968 ◽  
Author(s):  
Leonardo G. Ferreira ◽  
Glaucius Oliva ◽  
Adriano D. Andricopulo
Keyword(s):  
Drug Design ◽  
Anticancer Drug ◽  
Protein Interaction ◽  
Protein Protein Interaction

scholarly journals Biological Evaluation of Structurally Diverse Amaryllidaceae Alkaloids and their Synthetic Derivatives: Discovery of Novel Leads for Anticancer Drug Design

Planta Medica ◽  
2009 ◽  
Vol 75 (05) ◽  
pp. 501-507 ◽  
Author(s):  
Antonio Evidente ◽  
Artem Kireev ◽  
Aaron Jenkins ◽  
Anntherese Romero ◽  
Wim Steelant ◽  
...  
Keyword(s):  
Drug Design ◽  
Anticancer Drug ◽  
Biological Evaluation ◽  
Amaryllidaceae Alkaloids ◽  
Synthetic Derivatives

Farnesyltransferase as a target for anticancer drug design

Biopolymers ◽  
1997 ◽  
Vol 43 (1) ◽  
pp. 25-41 ◽  
Author(s):  
Yimin Qian ◽  
Saïd M. Sebti ◽  
Andrew D. Hamilton
Keyword(s):  
Drug Design ◽  
Anticancer Drug
Sign in / Sign up

Export Citation Format

Share Document